update on a phase i/ii study of ziftomenib in patients with r/r aml
Published 1 year ago • 150 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
3:55
updates in newly diagnosed and r/r aml
-
1:19:28
frcpath morphology and viva practice meeting 2 recording
-
44:14
llm evaluation in practice: timeseries evals
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study